Trend of depression and the use of psychiatric medications in U.S. veterans with hepatitis C during interferon-based therapy

American Journal of Gastroenterology

Volumn 102, Issue 11, 2007, Pages 2426-2433

  Jakiche, Antoine ^a   Paredez, Edward C ^b   Tannan, Pawan K ^a   Geppert, Cynthia ^a   Sontag, Vicki L ^a   Qualls, Clifford R ^c   Blair, David A ^b   Dettmer, Elizabeth L ^a  

^a VA Medical Center   (United States)

^b UNIVERSITY OF NEW MEXICO HOSPITAL   (United States)

^c UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; HYPNOTIC SEDATIVE AGENT; NEUROLEPTIC AGENT; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RECOMBINANT ALPHA2B INTERFERON; RIBAVIRIN;

ADULT; ARTICLE; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DEPRESSION; DRUG WITHDRAWAL; FEMALE; HEPATITIS C; HUMAN; IMMUNOTHERAPY; MALE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; STANDARDIZATION; TREATMENT OUTCOME; VETERAN;

ANALYSIS OF VARIANCE; ANTIDEPRESSIVE AGENTS; CHI-SQUARE DISTRIBUTION; DEPRESSION; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERONS; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; UNITED STATES; VETERANS;

EID: 35448941413     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2007.01425.x     Document Type: Article

References (28)

1. Roselle GA, Danko LH, Kralovic SM, et al. National Hepatitis C Surveillance Day in the Veterans Health Administration of the Department of Veterans Affairs. Mil Med 2002 167 : 756 9.
2. Austin GE, Jensen B, Leete J, et al. Prevalence of hepatitis C virus seropositivity among hospitalized US veterans. Am J Med Sci 2000 319 : 353 9.
3. Briggs ME, Baker C, Hall R, et al. Prevalence and risk factors for hepatitis C virus infection at an urban Veterans Administration medical center. Hepatology 2001 34 : 1200 5.
4. Cheung RC. Epidemiology of hepatitis C virus infection in American veterans. Am J Gastroenterol 2000 95 : 740 7.
5. Sloan KL, Straits-Troster KA, Dominitz JA, et al. Hepatitis C tested prevalence and comorbidities among veterans in the US Northwest. J Clin Gastroenterol 2004 38 : 279 84.
6. El-Serag HB, Kunik M, Richardson P, et al. Psychiatric disorders among veterans with hepatitis C infection. Gastroenterology 2002 123 : 476 82.
7. Nguyen HA, Miller AI, Dieperink E, et al. Spectrum of disease in U. S. veteran patients with hepatitis C. Am J Gastroenterol 2002 97 : 1813 20.
8. Bini EJ, Brau N, Currie S, et al. Prospective multicenter study of eligibility for antiviral therapy among 4,084 U. S. veterans with chronic hepatitis C virus infection. Am J Gastroenterol 2005 100 : 1772 9.
9. Muir AJ, Provenzale D. A descriptive evaluation of eligibility for therapy among veterans with chronic hepatitis C virus infection. J Clin Gastroenterol 2002 34 : 268 71.
10. Rowan PJ, Tabasi S, Abdul-Latif M, et al. Psychosocial factors are the most common contraindications for antiviral therapy at initial evaluation in veterans with chronic hepatitis C. J Clin Gastroenterol 2004 38 : 530 4.
11. Randloff L. The CES-D scale: A self-report depression scale for research in the general population. Appl Psychol Meas 1977 1 : 385 401.
12. Fried MW, Shiffman ML, Reddy KR, et al. Peginterferon alfa-2 a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002 347 : 975 82.
13. Manns MP, McHutchison JG, Gordon SC, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial. Lancet 2001 358 : 958 65.
14. McHutchison JG, Gordon SC, Schiff ER, et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med 1998 339 : 1485 92.
15. Clark CH, Mahoney JS, Clark DJ et al. Screening for depression in a hepatitis C population: The reliability and validity of the Center for Epidemiologic Studies Depression Scale (CES-D). J Adv Nurs 2002 40 : 361 9.
16. Loftis JM, Hauser P. The phenomenology and treatment of interferon-induced depression. J Affect Disord 2004 82 : 175 90.
17. Capuron L, Ravaud A. Prediction of the depressive effects of interferon alfa therapy by the patient's initial affective state. N Engl J Med 1999 340 : 1370.
18. Castera L, Zigante F, Bastie A, et al. Incidence of interferon alfa-induced depression in patients with chronic hepatitis C. Hepatology 2002 35 : 978 9.
19. Dieperink E, Ho SB, Thuras P, et al. A prospective study of neuropsychiatric symptoms associated with interferon-alpha-2b and ribavirin therapy for patients with chronic hepatitis C. Psychosomatics 2003 44 : 104 12.
20. Miyaoka H, Otsubo T, Kamijima K, et al. Depression from interferon therapy in patients with hepatitis C. Am J Psychiatry 1999 156 : 1120.
21. Pariante CM, Orru MG, Baita A, et al. Treatment with interferon-alpha in patients with chronic hepatitis and mood or anxiety disorders. Lancet 1999 354 : 131 2.
22. Schaefer M, Schmidt F, Folwaczny C, et al. Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups. Hepatology 2003 37 : 443 51.
23. Musselman DL, Lawson DH, Gumnick JF, et al. Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med 2001 344 : 961 6.
24. Hauser P, Khosla J, Aurora H, et al. A prospective study of the incidence and open-label treatment of interferon-induced major depressive disorder in patients with hepatitis C. Mol Psychiatry 2002 7 : 942 7.
25. Cawthorne CH, Rudat KR, Burton MS, et al. Limited success of HCV antiviral therapy in United States veterans. Am J Gastroenterol 2002 97 : 149 55.
26. Getachew Y, Browning JD, Prebis M, et al. Combination therapy for the treatment of hepatitis C in the veteran population: Higher than expected rates of therapy discontinuation. Aliment Pharmacol Ther 2004 20 : 629 36.
27. Morelli J, Kim CY, Willner IR. U. S. veterans' experience with rebetron in a nonstudy environment: Success or failure? Am J Gastroenterol 2002 97 : 2379 82.
28. Knott A, Dieperink E, Willenbring ML, et al. Integrated psychiatric/medical care in a chronic hepatitis C clinic: Effect on antiviral treatment evaluation and outcomes. Am J Gastroenterol 2006 101 : 2254 62.